You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 9, 2025

Claims for Patent: 6,458,924

✉ Email this page to a colleague

« Back to Dashboard

Summary for Patent: 6,458,924

Title:	Derivatives of GLP-1 analogs
Abstract:	The present invention relates to a pharmaceutical composition comprising a GLP-1 derivative having a lipophilic substituent; and a surfactant.
Inventor(s):	Knudsen; Liselotte Bjerre (Valby, DK), Huusfeldt; Per Olaf (K.o slashed.benhavn K, DK), Nielsen; Per Franklin (V.ae butted.rl.o slashed.se, DK)
Assignee:	Novo Nordisk A/S (Bagsvaerd, DK)
Application Number:	09/398,111
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 6,458,924
Patent Claims:	1. A glucagon-like peptide-1 (GLP-1) derivative of formula I (SEQ ID NO:2): wherein (a) the .epsilon.-amino group of Lys at position 26 is substituted with a lipophilic substituent optionally via a spacer, and (b) the lipophilic substituent is (i) CH.sub.3 (CH.sub.2).sub.n CO-- wherein n is 6, 8, 10, 12, 14, 16, 18, 20 or 22 (ii) HOOC(CH.sub.2).sub.m CO-- wherein m is 10, 12, 14, 16, 18, 20 or 22, or (iii) lithocholyl, and (c) the spacer is an amino acid residue except Cys, or the spacer is .gamma.-aminobutanoyl. 2. The GLP-1 derivative of claim 1, wherein the lipophilic substituent is linked to the .epsilon.-amino group of Lys via a spacer. 3. The GLP-1 derivative of claim 2, wherein the spacer is is .gamma.-glutamyl. 4. The GLP-1 derivative of claim 2, wherein the spacer is .beta.-asparagyl. 5. The GLP-1 derivative of claim 2, wherein the spacer is glycyl. 6. The GLP-1 derivative of claim 2, wherein the spacer is .gamma.-aminobutanoyl. 7. The GLP-1 derivative of claim 2, wherein the spacer is .beta.-alanyl. 8. A pharmaceutical composition comprising a GLP-1 derivative of claim 1 and a pharmaceutically acceptable vehicle or carrier. 9. The pharmaceutical composition of claim 8, further comprising an isotonic agent, a preservative and a buffer. 10. The pharmaceutical composition of claim 9, wherein the isotonic agent is sodium chloride, mannitol and glycerol. 11. The pharmaceutical composition of claim 9, wherein the preservative is phenol, m-cresol, methyl p-hydroxybenzoate or benzyl alcohol. 12. The pharmaceutical composition of claim 9, wherein the buffer is sodium acetate or sodium phosphate. 13. The pharmaceutical composition of claim 8, further comprising a surfactant. 14. The pharmaceutical composition of claim 8, further comprising zinc. 15. The pharmaceutical composition of claim 8, further comprising an antidiabetic agent. 16. The pharmaceutical composition of claim 15, wherein the antidiabetic agent is human insulin. 17. The pharmaceutical composition of claim 15, wherein the antidiabetic agent is a hypoglycemic agent. 18. The pharmaceutical composition of claim 8, further comprising an antiobesity agent. 19. A method of treating diabetes, comprising adminstering to a patient a therapeutically effective amount of a GLP-1 derivative of claim 1. 20. A method of treating obesity, comprising administering to a patient a therapeutically effective amount of a GLP-1 derivative of claim 1.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.